Steven M Greenberg Selected Research

Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)

8/2020

Association of Selective Serotonin Reuptake Inhibitor Use After Intracerebral Hemorrhage With Hemorrhage Recurrence and Depression Severity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven M Greenberg Research Topics

Disease

85	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 04/2024 - 01/2002
62	Cerebral Hemorrhage 03/2024 - 07/2003
31	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2006
28	Hemorrhage 05/2024 - 04/2004
20	Stroke (Strokes) 12/2023 - 09/2005
16	Cognitive Dysfunction 01/2023 - 11/2004
16	Hematoma 01/2019 - 12/2005
15	Dementia (Dementias) 01/2023 - 01/2002
12	Familial Cerebral Amyloid Angiopathy 07/2023 - 07/2008
12	Hemorrhagic Stroke 01/2021 - 01/2002
10	Ischemic Stroke 11/2023 - 07/2008
8	Siderosis 05/2024 - 07/2011
8	Cerebral Small Vessel Diseases 04/2024 - 10/2016
8	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2024 - 05/2011
8	Atrial Fibrillation 12/2023 - 07/2003
7	Disease Progression 02/2024 - 08/2011
7	Amyloid Plaque 01/2023 - 07/2005
7	Inflammation (Inflammations) 01/2022 - 02/2004
6	Brain Injuries (Brain Injury) 01/2023 - 11/2013
5	Hypertension (High Blood Pressure) 11/2022 - 12/2011
5	Edema (Dropsy) 04/2019 - 12/2005
4	App-Related Cerebroarterial Amyloidosis 03/2024 - 10/2019
4	Amyloidosis 12/2023 - 09/2008
3	Leukoencephalopathies 01/2022 - 04/2013
3	Rupture 01/2021 - 01/2009
3	Leukoaraiosis 01/2018 - 04/2013
3	Amyloid angiopathy 01/2017 - 03/2003
3	Diabetes Mellitus 01/2014 - 04/2004
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2012 - 11/2004
3	Heart Failure 02/2009 - 10/2006
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 11/2023 - 01/2018
2	Gliosis 08/2023 - 06/2015
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 08/2023 - 07/2008
2	Thromboembolism 01/2020 - 12/2008
2	Embolic Stroke 11/2018 - 04/2004
2	Atrophy 01/2018 - 01/2016
1	Neuroinflammatory Diseases 08/2023
1	Pathologic Processes 01/2023
1	Cavernous Hemangioma (Cavernous Angioma) 01/2021
1	Neurologic Manifestations (Neurological Manifestations) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Aphasia (Dysphasia) 04/2019
1	Subdural Hematoma (Subdural Hemorrhage) 04/2019

Drug/Important Bio-Agent (IBA)

62	Amyloid (Amyloid Fibrils)IBA 05/2024 - 01/2002
33	Biomarkers (Surrogate Marker)IBA 03/2024 - 08/2009
19	Amyloid beta-PeptidesIBA 03/2021 - 01/2002
19	Warfarin (Coumadin)FDA LinkGeneric 01/2019 - 07/2003
17	Apolipoproteins E (ApoE)IBA 11/2022 - 12/2010
12	AnticoagulantsIBA 11/2023 - 07/2003
10	Peptides (Polypeptides)IBA 01/2023 - 01/2002
9	ApolipoproteinsIBA 08/2020 - 06/2012
8	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2024 - 06/2008
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2002
6	IronIBA 05/2024 - 01/2018
6	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 12/2005
5	LipidsIBA 12/2023 - 01/2014
5	Matrix Metalloproteinases (MMPs)IBA 01/2023 - 12/2005
5	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 10/2019 - 11/2008
4	Hemostatics (Antihemorrhagics)IBA 11/2014 - 08/2008
3	Hemoglobins (Hemoglobin)IBA 11/2023 - 01/2019
3	Dabigatran FDA Link 11/2023 - 01/2011
3	CalciumIBA 01/2023 - 11/2016
3	CholesterolIBA 01/2021 - 06/2008
3	DNA (Deoxyribonucleic Acid)IBA 02/2017 - 09/2009
3	HemosiderinIBA 01/2014 - 07/2011
2	Minocycline (Cyclops)FDA LinkGeneric 02/2024 - 06/2015
2	aducanumabIBA 01/2022 - 01/2021
2	Nerve Growth Factors (Neurotrophins)IBA 11/2021 - 01/2021
2	Glucose-6-Phosphate Isomerase (Phosphoglucose Isomerase)IBA 11/2021 - 01/2021
2	FibrinIBA 01/2021 - 01/2019
2	CreatinineIBA 01/2021 - 01/2018
2	HDL CholesterolIBA 11/2016 - 01/2014
2	Genetic Markers (Genetic Marker)IBA 10/2016 - 12/2008
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 06/2015 - 09/2006
2	recombinant FVIIa (rFVIIa)FDA Link 01/2013 - 09/2006
2	Collagen Type IV (Type IV Collagen)IBA 04/2012 - 07/2008
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2011 - 11/2004
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 12/2023
1	N(4)-oleylcytosine arabinosideIBA 11/2023
1	Vitamin K FDA Link 11/2023
1	apixabanIBA 11/2023
1	Matrix Metalloproteinase InhibitorsIBA 01/2023
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2022
1	Waste Products (Waste Product)IBA 01/2022
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2022
1	Neurotransmitter Receptors (Neurotransmitter Receptor)IBA 01/2022
1	AN-1792IBA 01/2022
1	Antidepressive Agents (Antidepressants)IBA 01/2022
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 08/2020
1	ponezumabIBA 04/2019
1	Evans Blue (Blue, Evans)FDA Link 01/2019
1	estropipate (Ogen)FDA LinkGeneric 01/2019
1	Labetalol (Normodyne)FDA LinkGeneric 01/2019
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 01/2019

Therapy/Procedure

24	Therapeutics 01/2022 - 07/2003
4	Secondary Prevention 12/2023 - 05/2011
4	Immunotherapy 01/2022 - 02/2007
1	Blood Transfusion (Blood Transfusions) 12/2023
1	Off-Label Use 01/2021